Evidence map›Paper›PMID 16714598›Full record

ArticleInfection and immunity2006

Toll-like receptor 2 is required for control of pulmonary infection with Francisella tularensis.

Meenakshi Malik, Chandra Shekhar Bakshi, Bikash Sahay, Aaloki Shah, Steven A Lotz, Timothy J Sellati

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 108 citations in OpenAlex.

  1. Article
  2. Review
  3. mBio · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Efficacy of Resistance toFrontiers in immunology · 2017
    Article
  15. Innate Immune Recognition: Implications for the Interaction ofFrontiers in cellular and infection microbiology · 2017
    Review
  16. Article
  17. Mitogen-activated protein kinases (MAPKs) are modulated during Francisella tularensis infection, but inhibition of extracellular-signal-regulated kinases (ERKs) is of limited therapeutic benefit.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2016
    Article
  18. Article
  19. Journal of bioterrorism & biodefense · 2016
    Article
  20. Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Meenakshi MalikCenter for Immunology and Microbial Disease, Albany Medical College, 47 New Scotland Avenue, MC151, ME205B, Albany, NY 12208-3479, USA.
Chandra Shekhar Bakshi
Bikash Sahay
Aaloki Shah
Steven A Lotz
Timothy J Sellati
Albany Medical Center Hospital · US

Funding

TLR2/NLR Signal Regulation of Protective Immunity to F. TularensisP01AI056320 · NIAID · ALBANY MEDICAL COLLEGE · PI METZGER, DENNIS W · 2003 to 2016
$22.9M
CD14 AND THE IMMUNOPATHOGENESIS OF CHRONIC LYME DISEASER01AI054546 · NIAID · ALBANY MEDICAL COLLEGE · PI SELLATI, TIMOTHY J · 2004 to 2008
$1.7M
NIAID NIH HHS P01 AI-056320NIAID NIH HHS P01 AI056320NIAID NIH HHS R01 AI054546
6 · The paper itself

Abstract

Toll-like receptor 2 (TLR2) deficiency enhances murine susceptibility to infection by Francisella tularensis as indicated by accelerated mortality, higher bacterial burden, and greater histopathology. Analysis of pulmonary cytokine levels revealed that TLR2 deficiency results in significantly lower levels of tumor necrosis factor alpha and interleukin-6 but increased amounts of gamma interferon and monocyte chemoattractant protein 1. This pattern of cytokine production may contribute to the exaggerated pathogenesis seen in TLR2-/- mice. Collectively, these findings suggest that TLR2 plays an important role in tempering the host response to pneumonic tularemia.

Indexed as

AnimalsInterferon-gammaInterleukin-6LungMiceMice, Inbred C57BLPneumonia, BacterialToll-Like Receptor 2TularemiaTumor Necrosis Factor-alphaInterferon-gammaInterleukin-6Tlr2 protein, mouseToll-Like Receptor 2Tumor Necrosis Factor-alpha

Identifiers

PMID16714598
PMCPMC1479238
OpenAlexW2053521828

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.